Physician profile
Stephanie E Liebmann
NPI 1366649253
$1,364.44
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $728 · 2023: $619 · 2024: $17.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $459.53 | 2022-2023 | |
| Novo Nordisk INC | $143.22 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $99.73 | 2022-2023 | Breztri |
| Lilly USA, LLC | $95.82 | 2022-2023 | Mounjaro, Trulicity |
| Pfizer INC. | $71.84 | 2022-2023 | |
| Glaxosmithkline, LLC. | $68.98 | 2022-2023 | Shingrix, Bexsero |
| Biohaven Pharmaceutical Holding Company LTD. | $64.16 | 2022 | |
| Abbott Laboratories | $62.71 | 2022-2023 | Freestyle Libre 3 |
| Sanofi Pasteur INC. | $50.55 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.70 | 2022-2023 | |
| Exact Sciences Corporation | $47.49 | 2023-2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $43.11 | 2022-2023 | |
| Nevro Corp. | $37.40 | 2023 | Senza |
| Edwards Lifesciences Corporation | $30.18 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $26.70 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $15.32 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Liebmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.